Where does Ross Leimberg work?

Ross Leimberg is Founder / EIR at 82VS.

Where did Ross Leimberg go to school?

Ross Leimberg studied at Harvard Business School (Master of Business Administration - MBA); University of Pennsylvania (BAS, Bioengineering); The Wharton School (BS in Econ, Finance).

Ross Leimberg

Investor

Founder / EIR at 82VS

Boston, Massachusetts, United States

Find your path to Ross

331 people in our graph share verified history with Ross — schools, employers, funds. One of them is your warm intro.

Nicole GaudelliunlockedRoss: together at Harvard University (2014)

×2Ross: together at Resilience

×2Ross: together at AbbVie

×2Ross: together at Pfizer Pharmaceuticals

About

Ross Leimberg is COO and interim CEO at Cantai Therapeutics, which he founded. His professional background spans business development, transactions, commercial strategy, operations, and life science entrepreneurship.

Experience

Cantai TherapeuticsCOO and interim CEOcurrent2024 — present
Alloy Therapeutics, Inc.Venture Partner at 82VS | Alloy Therapeutics Venture Studiocurrent2022 — presentWaltham, Massachusetts, United States
ResilienceHead of Business Development2021 — 2022Boston
Carisma TherapeuticsBoard Observer2017 — 2021Philadelphia, PA
AbbVieDirector2017 — 2021Cambridge, MA
AbbVieSenior Manager2014 — 2017Cambridge, MA
Palleon PharmaceuticalsBoard Observer2016 — 2021Waltham, Massachusetts, United States
Accelerator Life Science PartnersBoard Observer2015 — 2021Seattle / New York
Harvard Community Action PartnersVolunteer2013 — 2021
Harvard UniversityBlavatnik Fellow in Life Science Entrepreneurship2013 — 2014Greater Boston Area
Locust Walk PartnersAssociate2012 — 2014Cambridge, MA
SR OneIntern2011Cambridge, MA
Pfizer PharmaceuticalsSenior Analyst, BD, Portfolio Analytics, Decision Support, Early Commercial Development2007 — 2010
ZS AssociatesAssociate2006 — 2007

Skills & more

Strategy37Business Development12Healthcare4Finance3Investments3Portfolio Management2Financial Modeling4Corporate Development18Due Diligence4Mergers & Acquisitions2Business Strategy5Biotechnology22

+3 more

Private EquityVenture CapitalPharmaceutical Industry

From Ross's professional profile.

Colleagues at 82VS

Andrei Ramirez-Valdez

Venture Associate at 82VS

Andrew Peterson

Founder / EIR at 82VS

Arthur Suckow

Investor at 82VS

Caitlin Tolman

Chief Operating Officer at 82VS

Colby Jordan

Vice President, Capital Formation at 82VS

Dongxing Zha

Founder / EIR at 82VS

Errik Anderson

Board Director at Basecamp Fund

Hemanta Baruah

Founder / EIR at 82VS

Frequently asked questions

Who is Ross Leimberg?: Ross Leimberg is COO and interim CEO at Cantai Therapeutics, which he founded. His professional background spans business development, transactions, commercial strategy, operations, and life science entrepreneurship.
Where does Ross Leimberg work?: Ross Leimberg is Founder / EIR at 82VS.
Where did Ross Leimberg go to school?: Ross Leimberg studied at Harvard Business School (Master of Business Administration - MBA); University of Pennsylvania (BAS, Bioengineering); The Wharton School (BS in Econ, Finance).

Founder mafias

Harvard Business School mafia892

Also came through, then founded or led a company.

Tim DraperMBAFounded Draper Associates Mike Maples JrMBAFounded Pattern Breakers Hristo BorisovOPM Class 64Founded Payhawk Noubar AfeyanVisiting LecturerFounded ProFound Therapeutics +13 Wade MyersMBAFounded RealManage +6 Wade MyersMBAFounded RealManage +6

+ 885 more

The Wharton School mafia568

Also came through, then founded or led a company.

Kunal BahlMarketing and Operations StrategyFounded Snapdeal Jack AbrahamBachelors of Science in Economics *Dropped outFounded Atomic Labs +3 Gleb ChuvpiloMaster of Business Administration (MBA)Founded Thor Directed Energy +6 Ankur JainBachelor of Science (BS)Founded Kairos +3 Jagmeet LambaMBAFounded Certa +3 Edward LandoBachelor's DegreeFounded Link +2

+ 561 more

AbbVie mafia13

Also came through, then founded or led a company.

Evan MurphySenior Software EngineerFounded Zitara +1 Matthew RastovacSoftware Engineering InternFounded Atmos +1 Nick GasbarroGovernment Affairs InternFounded Cognizant Donmienne LeungDirector II, Head of AbbVie Ventures EuropeFounded ThirtyFiveBio Limited Jim Sullivan, Ph.D.Vice President Global DiscoveryFounded Vanquabio Yuga PatelAutomation Engineering InternFounded Ekpa

+ 6 more

82VS mafia8

Also came through, then founded or led a company.

Errik AndersonGeneral PartnerFounded Cantai Therapeutics +5 Andrew PetersonFounder / EIRFounded Aldebaran Therapeutics +1 Colby JordanVice President, Capital FormationFounded New North Ventures Sudhir AgrawalAdvisorFounded Aldebaran Therapeutics Michael KalosAdvisorFounded IpiNovyx Bio Arthur SuckowAdvisorFounded DTx Pharma

+ 1 more

Carisma Therapeutics mafia2

Also came through, then founded or led a company.

Sandy ZweifachChairman of the BoardFounded Imidomics

Same school

Also attended Harvard Business School2,000

Brad GerstnerFounder & CEO of Altimeter Capital Aileen LeeFounder & Managing Partner of Cowboy Ventures Jim BreyerFounder & CEO of Breyer Capital Tim DraperFounder of Draper Associates Mike Maples JrCo-founding Partner at Floodgate Mamoon HamidPartner at Kleiner Perkins

+ 1,994 more

Also attended University of Pennsylvania1,233

Brian ActonCo-founder of WhatsApp; co-founder of Signal Foundation Kunal BahlCo-founder of Snapdeal; co-founder of Titan Capital Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychology Nancy WangInvestor at Felicis Ventures Leah von SiemensPartner at Manta Ray Ventures Eghosa OmoiguiFounder and Managing General Partner at EchoVC Partners

+ 1,227 more

Also attended The Wharton School2,000

Fred WilsonCo-founder & Partner at Union Square Ventures Sarah GuoFounder & General Partner of Conviction Josh KopelmanFounder and Partner at First Round Capital Aydin SenkutFounder & Managing Partner at Felicis Kunal BahlCo-founder of Snapdeal; co-founder of Titan Capital Jack AbrahamFounder, CEO & Managing Partner of Atomic

+ 1,994 more

Shared employers

Also worked at AbbVie44

Nick GasbarroChief of Staff at QED Investors Charles White, Ph.D.Principal at Illumina Ventures Laura QuockCBO-in-Residence at Versant Ventures Manik PasrichaVice President at Titan Capital Jennifer SmoterChief Communications & Governance Officer at Takeda Ventures Takehiko SawabeDirector at Beyond Next Ventures

+ 38 more

Also worked at Palleon Pharmaceuticals7

Katarina PancePrincipal at SR One Capital Management NikolaInvestment Committee Member at ACF Investors Nikola TrbovicManaging Partner at SV Health Investors Lori HuManaging Director at Vertex Ventures HC Dr. Jens EcksteinAdvisor at Apollo Health Ventures Deepa PakianathanGeneral Partner at Delphi Ventures

+ 1 more

Also worked at Harvard University423

Nathan BlecharczykCo-founder & CSO of Airbnb Ryan SheaCo-founder of Blockstack (Stacks)Rachel HansenInvestor at Index Ventures Dave MunichielloInvestor at GV (Google Ventures)Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Logan HilleLife Sciences Analyst at CincyTech

+ 417 more

Also worked at SR One32

Freya Svedberg-KeatingInvestor at Medicxi Jake BauerVenture Partner at ARCH Venture Partners Aleks Radovic-MorenoPartner at Longwood Fund Vikas GoyalPartner at Longwood Fund Simeon J. GeorgeFounder & CEO at SR One Capital Management Rajeev DadooCOO & Managing Partner at SR One Capital Management

+ 26 more